Next Article in Journal
Agenesis and Hypomyelination of Corpus Callosum in Mice Lacking Nsun5, an RNA Methyltransferase
Next Article in Special Issue
Spatiotemporal Regulation of Rho GTPases in Neuronal Migration
Previous Article in Journal
Amyloid Precursor Protein (APP) and GABAergic Neurotransmission
Previous Article in Special Issue
Building Blood Vessels—One Rho GTPase at a Time
Open AccessReview

RhoGTPase in Vascular Disease

1
Cardiovascular and Pulmonary Research Lab, Department of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO 80045, USA
2
Department of Pediatrics, Anschutz Medical Campus, University of Colorado, Aurora, CO 80045, USA
3
Pulmonary Sciences and Critical Care Medicine, Department of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO 80045, USA
4
Rocky Mountain Regional VA Medical Center, Aurora, CO 80045, USA
*
Author to whom correspondence should be addressed.
Cells 2019, 8(6), 551; https://doi.org/10.3390/cells8060551
Received: 18 March 2019 / Revised: 24 May 2019 / Accepted: 27 May 2019 / Published: 6 June 2019
(This article belongs to the Special Issue Rho GTPases in Health and Disease)
Ras-homologous (Rho)A/Rho-kinase pathway plays an essential role in many cellular functions, including contraction, motility, proliferation, and apoptosis, inflammation, and its excessive activity induces oxidative stress and promotes the development of cardiovascular diseases. Given its role in many physiological and pathological functions, targeting can result in adverse effects and limit its use for therapy. In this review, we have summarized the role of RhoGTPases with an emphasis on RhoA in vascular disease and its impact on endothelial, smooth muscle, and heart and lung fibroblasts. It is clear from the various studies that understanding the regulation of RhoGTPases and their regulators in physiology and pathological conditions is required for effective targeting of Rho. View Full-Text
Keywords: RhoGTPases; endothelial; smooth muscle; fibroblasts; vascular; therapeutics RhoGTPases; endothelial; smooth muscle; fibroblasts; vascular; therapeutics
Show Figures

Graphical abstract

MDPI and ACS Style

Strassheim, D.; Gerasimovskaya, E.; Irwin, D.; Dempsey, E.C.; Stenmark, K.; Karoor, V. RhoGTPase in Vascular Disease. Cells 2019, 8, 551.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop